Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

2021 ◽  
Vol 61 (4) ◽  
pp. 590-602
Author(s):  
Dionne M. Hines ◽  
Shweta Shah ◽  
Jasjit K. Multani ◽  
Rolin L. Wade ◽  
Dawn C. Buse ◽  
...  
Keyword(s):  
United States ◽  
Medication Adherence ◽  
Patient Characteristics ◽  
The United States ◽  
Treatment Patterns

Chronic spontaneous urticaria in the United States: patient characteristics and treatment patterns

2021 ◽  
Author(s):  
Sarah P. Pourali ◽  
Yasmin Gutierrez ◽  
Alison H. Kohn ◽  
Jeffrey R. Rajkumar ◽  
Madison E. Jones ◽  
...  
Keyword(s):  
United States ◽  
Patient Characteristics ◽  
The United States ◽  
Treatment Patterns ◽  
Chronic Spontaneous Urticaria

scholarly journals Trichotillomania in the United States: An epidemiologic study of patient characteristics, comorbidities, and treatment patterns

2021 ◽  
Vol 27 (8) ◽  
Author(s):  
Yasmin Gutierrez ◽  
Madison E Jones ◽  
Jeffrey R Rajkumar ◽  
Alison H Kohn ◽  
Sarah P Pourali ◽  
...  
Keyword(s):  
United States ◽  
Epidemiologic Study ◽  
Patient Characteristics ◽  
The United States ◽  
Treatment Patterns

scholarly journals Patient characteristics, treatment patterns, and outcomes of Rickettsial diseases among a commercially insured population in the United States, 2005–2017

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Alison M. Binder ◽  
Paige A. Armstrong
Keyword(s):  
United States ◽  
Spotted Fever ◽  
Severe Disease ◽  
Descriptive Analysis ◽  
Febrile Illness ◽  
Patient Characteristics ◽  
The United States ◽  
Treatment Patterns ◽  
Recommended Treatment ◽  
Rickettsial Diseases

AbstractRickettsial diseases (RDs) are transmitted to humans by ectoparasites, including ticks and fleas. Symptoms range from mild febrile illness, to severe disease or death. Doxycycline is the treatment of choice for patients of all ages; early treatment based on clinical diagnosis is critical to prevent severe outcomes. We conducted a descriptive analysis using insurance claims data captured by IBM MarketScan® research databases to describe demographics, treatment patterns, and outcomes of patients diagnosed with RDs in the United States during 2005–2017. Overall, 14,830 patients had a RD diagnosis during 2005–2017; 7,517 (50.7%) spotted fever rickettsiosis (SFR), 4,571 ( 30.8%) ehrlichiosis, 1,362 (9.2%) typhus group rickettsiosis (TGR), and 1,193 (8.0%) other rickettsial diseases. Among all patients diagnosed, 53.1% received doxycycline. Prescription rates varied by diagnosis and age; 24.1% of TGR and 61.1% of SFR patients received doxycycline; 23.9% of persons < 8 years received doxycycline, compared with 47.7% for 8–17 years, and 55.4% for ≥ 18 years. RDs are frequently diagnosed in the outpatient population; however, providers prescribed the recommended treatment to about half of patients. Continued education of treatment recommendations is critical to prevent severe outcomes.

scholarly journals Alopecia areata in the United States: a ten-year analysis of patient characteristics, comorbidities, and treatment patterns

2021 ◽  
Vol 27 (10) ◽  
Author(s):  
Yasmin Gutierrez ◽  
Sarah P Pourali ◽  
Madison E Jones ◽  
Jeffrey R Rajkumar ◽  
Alison H Kohn ◽  
...  
Keyword(s):  
United States ◽  
Alopecia Areata ◽  
Patient Characteristics ◽  
The United States ◽  
Treatment Patterns
Sign in / Sign up

Export Citation Format

Share Document